Related Experiment Video
Updated: Aug 8, 2026

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning
Published on: October 30, 2012
Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation
V L Seyfert1, S McMahon, W Glenn
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6082.
Insights
The immediate/early gene Egr-1 is rapidly expressed in B lymphocytes upon antigen receptor activation. Its induction is linked to protein kinase C signaling, not calcium levels, influencing gene expression changes.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Immediate/early genes like Egr-1 play crucial roles in cellular responses to external stimuli.
- Egr-1 encodes a transcription factor involved in coupling receptor signals to gene expression.
- B lymphocyte activation involves complex signaling pathways initiated by the B cell antigen receptor.
Purpose of the Study:
- To investigate the expression pattern of the Egr-1 gene in murine B lymphocytes following antigen receptor stimulation.
- To elucidate the specific signaling pathways, particularly protein kinase C and calcium signaling, that regulate Egr-1 induction in B cells.
- To understand the role of Egr-1 as a mediator of B cell activation and gene expression changes.
Main Methods:
- Murine B lymphocytes were stimulated with anti-receptor antibodies to induce receptor crosslinking.
- Quantitative analysis of Egr-1 mRNA and protein expression over time.
- Inhibition studies using actinomycin D to assess dependence on new protein synthesis.
- Pharmacological manipulation using protein kinase C activators (PMA, SC-9) and inhibitors (H7, sangivamycin, staurosporin).
- Investigation of Egr-1 induction in response to elevated intracellular free calcium levels.
- Preliminary promoter mapping to identify cis-regulatory elements involved in Egr-1 regulation.
Main Results:
- Egr-1 mRNA expression was rapidly and transiently induced by anti-receptor antibodies, returning to basal levels by 6 hours.
- Egr-1 protein expression was more sustained, detectable up to 12 hours.
- Egr-1 induction was independent of de novo protein synthesis and sensitive to actinomycin D, indicating a primary response.
- Egr-1 mRNA induction was not observed upon elevation of intracellular free calcium.
- Pharmacological activation of protein kinase C (PKC) with PMA and SC-9 mimicked the kinetics of anti-receptor antibody-induced Egr-1 expression.
- PKC inhibitors (H7, sangivamycin, staurosporin) blocked anti-receptor antibody-induced Egr-1 expression.
- Preliminary promoter analysis suggested that PMA and anti-receptor antibody signaling converge on common cis-regulatory elements.
Conclusions:
- Egr-1 is a key immediate/early gene rapidly induced in B lymphocytes upon antigen receptor activation.
- The signaling pathway for Egr-1 induction in B cells is primarily mediated by protein kinase C, not intracellular calcium.
- Egr-1 acts as a crucial link between B cell antigen receptor stimulation and downstream gene expression changes, potentially influencing cell cycle progression.
Abstract:
We have studied the expression of an immediate/early type gene, Egr-1, in murine B lymphocyte responses to Ag receptor-generated signals. The Egr-1 gene encodes a zinc finger protein with sequence-specific DNA binding activity and is believed to act as an intracellular "third messenger," to couple receptor-generated signals to activation-associated changes in gene expression. We show here that Egr-1 mRNA expression is rapidly and transiently (returning to basal levels by 6 h) induced after receptor crosslinking with anti-receptor antibodies. Egr-1 protein expression is more prolonged, maintaining detectable levels through 12 h. The induction of Egr-1 is a primary response to Ag receptor signaling, as it is independent of new protein synthesis and is inhibited by actinomycin D. We have also examined the linkage of Egr-1 to known signaling pathways associated with G0 to G1 transition by these cells in response to signals generated through the B cell Ag receptor. Egr-1 mRNA was not induced after elevation of intracellular free Ca2+. In contrast, the pharmacologic agents PMA and SC-9, which directly activate protein kinase C, both cause marked increases in Egr-1 mRNA levels with the same kinetics as observed after anti-receptor antibody stimulation. Further, the protein kinase C inhibitors H7, sangivamycin, and staurosporin block anti-receptor antibody-induced expression of Egr-1, thus, B cell Ag receptor-linked Egr-1 expression is likely coupled to the protein kinase C component of transmembrane signaling. Preliminary promoter mapping studies are consistent with this conclusion, because both PMA and anti-receptor antibody act through the same or overlapping cis-regulatory elements.
More Related Videos
11:02A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide
Published on: October 18, 2014
10:43Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
Published on: November 6, 2019
Related Concept Videos
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
Activation and Inactivation of G Proteins
IP3/DAG Signaling Pathway
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...